| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |